SURMOUNT BIO
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Jan 2023)
What this means for you
This application is over — abandoned 16 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88521089
- Mark type
- Stylized text
- Filed
- 18 Jul 2019
- Published for opposition
- 15 Oct 2019
- Abandoned
- 16 Jan 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Anti-cancer preparations; Biological preparations for the treatment of cancer; Digestives for pharmaceutical purposes; Drug delivery agents in the form of a capsule, pill, or liquid that facilitate the delivery of pharmaceutical preparations; Medical preparations for the treatment of cancer, cystic fibrosis, heart disease, and AIDS; Medicinal infusions for treating Cancer, cystic fibrosis, heart disease, and AIDS; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations for the treatment and prevention of Cancer, cystic fibrosis, heart disease, and AIDS; Pharmaceutical products for the prevention and treatment of cancer; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Therapeutic pharmaceutical for the treatment of Cancer, cystic fibrosis, heart disease, and AIDS; Unit dose capsules sold empty for pharmaceutical use
Owner
- ElevateBio, LLC, Cambridge, MA, US
- ElevateBio, LLC, Cambridge, MA, US
Prosecution history
- 17 Jan 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Jan 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 20 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 May 2022 — SOU EXTENSION 5 GRANTED
- 17 May 2022 — SOU EXTENSION 5 FILED
- 17 May 2022 — SOU TEAS EXTENSION RECEIVED
- 26 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Nov 2021 — SOU EXTENSION 4 GRANTED
- 24 Nov 2021 — SOU EXTENSION 4 FILED
- 24 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 18 Nov 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Nov 2021 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 18 Nov 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Nov 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED